Your browser is no longer supported. Please, upgrade your browser.
Settings
CPRX Catalyst Pharmaceuticals, Inc. daily Stock Chart
CPRX [NASD]
Catalyst Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.21 Insider Own7.90% Shs Outstand88.54M Perf Week-9.22%
Market Cap278.90M Forward P/E- EPS next Y-0.28 Insider Trans0.29% Shs Float72.49M Perf Month-11.27%
Income-17.20M PEG- EPS next Q-0.06 Inst Own65.70% Short Float1.51% Perf Quarter2.94%
Sales- P/S- EPS this Y12.90% Inst Trans52.67% Short Ratio1.03 Perf Half Y15.81%
Book/sh0.37 P/B8.51 EPS next Y-27.30% ROA-45.80% Target Price6.19 Perf Year181.25%
Cash/sh0.38 P/C8.23 EPS next 5Y- ROE-49.10% 52W Range1.08 - 4.51 Perf YTD-19.44%
Dividend- P/FCF- EPS past 5Y5.80% ROI- 52W High-30.16% Beta1.30
Dividend %- Quick Ratio12.60 Sales past 5Y- Gross Margin- 52W Low191.67% ATR0.17
Employees18 Current Ratio12.60 Sales Q/Q- Oper. Margin- RSI (14)33.90 Volatility5.50% 5.19%
OptionableYes Debt/Eq0.00 EPS Q/Q-3.30% Profit Margin- Rel Volume0.66 Prev Close3.15
ShortableYes LT Debt/Eq0.00 EarningsMar 14 AMC Payout- Avg Volume1.06M Price3.15
Recom2.00 SMA20-7.20% SMA50-15.41% SMA2005.66% Volume706,216 Change0.00%
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Sep-06-13Reiterated Aegis Capital Buy $3.50 → $4
Apr-18-13Initiated Aegis Capital Buy $2.50
Aug-27-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
Oct-01-09Upgrade Merriman Sell → Neutral
May-29-09Downgrade Merriman Curhan Ford Buy → Sell
May-29-09Downgrade Hapoalim Neutral → Underperform
Dec-15-08Initiated Merriman Curhan Ford Buy
Nov-28-07Initiated Rodman & Renshaw Mkt Outperform $9
Jan-31-07Initiated Stifel Nicolaus Buy $9
Jan-05-07Initiated First Albany Buy $10
Feb-15-18 07:35AM  Detailed Research: Economic Perspectives on Carbo Ceramics, Consolidated Communications, Catalyst Pharmaceuticals, Office Depot, ImmunoGen, and Cedar Realty Trust What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-12-18 08:03AM  Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse® GlobeNewswire
Feb-07-18 08:03AM  Catalyst Pharmaceuticals to Present at Two Upcoming Investor Conferences GlobeNewswire
Dec-02-17 10:33AM  3 Drug Stocks That Soared This Week: Are They Buys? Motley Fool
Nov-30-17 02:07PM  Catalyst Pharmaceuticals, Inc. Announces Closing of Previously Announced Public Offering GlobeNewswire +8.31%
08:20AM  Analysis: Positioning to Benefit within Office Depot, ImmunoGen, Cedar Realty Trust, Carbo Ceramics, Consolidated Communications, and Catalyst Pharmaceuticals Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-28-17 09:17AM  Catalyst Pharmaceuticals, Inc. Prices Previously Announced Public Offering of Common Stock Marketwired +10.25%
Nov-27-17 04:03PM  Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
06:30AM  Catalyst Pharmaceuticals Announces Positive Top-Line Results from Second Phase 3 Clinical Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome GlobeNewswire
Nov-21-17 08:03AM  Catalyst Pharmaceuticals Announces Phase 2 Study of Firdapse® in Ambulatory Patients with Spinal Muscular Atrophy (SMA) GlobeNewswire +6.86%
Nov-08-17 06:33PM  Catalyst reports 3Q loss Associated Press
04:41PM  Catalyst Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
09:59AM  Have Investors Already Priced In Catalyst Pharmaceuticals Incs (CPRX) Growth? Simply Wall St.
Nov-06-17 10:33AM  What's in Store for Catalyst (CPRX) This Earnings Season? Zacks +5.70%
Nov-01-17 08:03AM  Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 9th, 2017 GlobeNewswire
Oct-31-17 08:03AM  Catalyst Pharmaceuticals Completes Enrollment in Second Phase 3 Trial of Firdapse® in Patients with Lambert-Eaton Myasthenic Syndrome GlobeNewswire +7.92%
Oct-16-17 08:03AM  Catalyst Pharmaceuticals to Present at 16th Annual BIO Investor Forum GlobeNewswire
Aug-30-17 08:03AM  Catalyst Pharmaceuticals Provides Update on the Status of its Firdapse Development Activities GlobeNewswire
Aug-10-17 06:40AM  Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-09-17 10:00PM  Catalyst reports 2Q loss Associated Press
04:30PM  Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
Aug-01-17 08:03AM  Catalyst Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10th, 2017 GlobeNewswire -6.12%
Jul-12-17 08:10AM  Today's Research Reports on Trending Tickers: Nektar Therapeutics and Catalyst Pharmaceuticals Inc. Accesswire
Jun-26-17 08:03AM  Catalyst Pharmaceuticals Joins Russell 3000 Index GlobeNewswire
Jun-07-17 11:05AM  Three Junior Biotechs Ready to Run Investopedia
Jun-01-17 08:03AM  Catalyst Pharmaceuticals to Present at the Jefferies 2017 Healthcare Conference GlobeNewswire +5.19%
May-17-17 08:03AM  Catalyst Pharmaceuticals to Present at the Antiepileptic Drug and Device Trials XIV Symposium GlobeNewswire
May-12-17 11:26AM  Catalyst Pharmaceuticals Receives 2017 Beacon Council Award for Contributions in Life Sciences & Healthcare GlobeNewswire +5.98%
May-11-17 07:30AM  Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call Accesswire
May-10-17 05:34PM  Catalyst reports 1Q loss Associated Press
04:35PM  Catalyst Pharmaceuticals Announces First Quarter 2017 Financial Results and Provides Corporate Update GlobeNewswire
11:25AM  Catalyst Pharmaceuticals Announces Poster Presentation of MuSK-MG clinical data at the 13th International Conference on Myasthenia Gravis and Related Disorders GlobeNewswire
May-02-17 06:40PM  What's in Store for Catalyst (CPRX) Stock in Q1 Earnings? Zacks
08:03AM  Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Thursday, May 11th, 2017 GlobeNewswire
Mar-28-17 09:30AM  Catalyst Pharmaceuticals and ZIOPHARM Oncology Bounce Up On FDA Phase News Accesswire -5.47%
08:15AM  Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%
Mar-24-17 01:04PM  CATALYST PHARMACEUTICALS, INC. Financials
Mar-23-17 09:47AM  Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse
Mar-21-17 09:30AM  Financials of Aurinia Pharmaceuticals and Catalyst Pharmaceuticals are Getting Stability Accesswire
Mar-16-17 12:03PM  Catalyst Pharmaceuticals Inc (CPRX): Heres Whats Next Insider Monkey
12:03PM  Catalyst Pharmaceuticals Inc (CPRX): Heres Whats Next at Insider Monkey
Mar-15-17 04:51PM  Catalyst reports 4Q loss Associated Press +32.48%
04:44PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:32PM  Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2016 Financial Results and Provides Corporate Update GlobeNewswire
03:17PM  Catalyst Pharma Neuromuscular Drug Succeeds In Study Investopedia
03:17PM  Catalyst Pharma Neuromuscular Drug Succeeds In Study at Investopedia
01:19PM  Heres Why Traders Are Piling Into These Five Stocks Insider Monkey
01:19PM  Heres Why Traders Are Piling Into These Five Stocks at Insider Monkey
12:10PM  Wednesdays Biggest Biopharma Movers
08:58AM  Catalyst Pharma shares jump 22% premarket on news of positive trial results for rare disease MarketWatch
08:58AM  Catalyst Pharma shares jump 22% premarket on news of positive trial results for rare disease at MarketWatch
08:57AM  Catalyst Pharma's neuromuscular drug succeeds in study Reuters
08:19AM  Catalyst Pharma's neuromuscular drug succeeds in study Reuters
08:03AM  Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored Trial of Firdapse® in treating MuSK Antibody Positive Myasthenia Gravis GlobeNewswire
07:07AM  Q4 2016 Catalyst Pharmaceuticals Inc Earnings Release - After Market Close
Mar-10-17 08:03AM  Catalyst Pharmaceuticals to Present at the 29th Annual ROTH Conference GlobeNewswire
Mar-09-17 08:03AM  Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Thursday, March 16th, 2017 GlobeNewswire
Mar-07-17 09:32AM  Catalyst Pharma (CPRX): What???s in Store in Q4 Earnings?
Feb-27-17 08:03AM  Catalyst Pharmaceuticals Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases GlobeNewswire
Feb-09-17 04:05PM  Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphreys 2017 Orphan Drug Day GlobeNewswire
Dec-16-16 08:16AM  Harvard Bioscience, Inc. (HBIO): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-15-16 08:44AM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:03AM  Catalyst Pharmaceuticals Announces First Patient Enrolled in Second Phase 3 Trial of Firdapse in Lambert-Eaton myasthenic syndrome (LEMS) GlobeNewswire
Dec-08-16 08:39AM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:03AM  Catalyst Pharmaceuticals Provides Update on its Clinical Trial for Patients with Congenital Myasthenic Syndromes GlobeNewswire
Dec-01-16 08:46AM  Catalyst Pharmaceuticals, Inc. :CPRX-US: Earnings Analysis: Q3, 2016 By the Numbers : December 1, 2016
Nov-21-16 08:03AM  Catalyst Pharmaceuticals to Participate in the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-14-16 08:35AM  Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma
Nov-09-16 05:59PM  Catalyst reports 3Q loss
05:02PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:21PM  Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update GlobeNewswire
04:15PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
07:07AM  Q3 2016 Catalyst Pharmaceuticals Inc Earnings Release - After Market Close
Nov-07-16 08:25AM  Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise?
Nov-03-16 08:37AM  Catalyst Reaches Agreement with FDA (CPRX) at Investopedia
Nov-01-16 01:28PM  Catalyst Pharmaceuticals Inc (CPRX) Isnt Out Of The Woods With Firdapse Just Yet at Insider Monkey
08:03AM  Catalyst Pharmaceuticals to Hold Third Quarter Financial Results Conference Call and Webcast on Thursday, November 10th, 2016 GlobeNewswire
Oct-31-16 11:15AM  Research Reports Coverage on Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine Biosciences, and Galectin Therapeutics PR Newswire +6.92%
08:13AM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:03AM  Catalyst Pharmaceuticals Receives Special Protocol Assessment (SPA) from the FDA for Second Phase 3 Clinical Trial Evaluating Firdapse for the Treatment of LEMS GlobeNewswire
Oct-13-16 08:03AM  Catalyst Pharmaceuticals to Present at 15th Annual BIO Investor Forum GlobeNewswire +10.32%
Oct-05-16 12:36PM  Heres Why Catalyst Pharmaceuticals, Resolute Energy, Nutanix & Two Other Stocks Are Trading Higher Today at Insider Monkey +30.36%
12:25PM  One Reason Why Catalyst Pharmaceuticals (CPRX) Stock Is Jumping Today
06:15AM  Catalyst Pharma upgraded by Piper Jaffray
Oct-03-16 08:31AM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule +5.50%
Sep-21-16 01:20PM  Catalyst Pharmaceuticals, Inc. :CPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 21, 2016
Sep-20-16 06:02AM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F
Sep-19-16 05:01PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:03AM  Catalyst Pharmaceuticals Announces Publication of CPP-115 Clinical Efficacy Data for Infantile Spasms in Epilepsy & Behavior Case Reports GlobeNewswire
Sep-14-16 08:03AM  Catalyst Pharmaceuticals Announces Launch of Expanded Access Program Website and Participation at the American Association of Neuromuscular & Electrodiagnostic Medicine Conference GlobeNewswire
Sep-08-16 08:03AM  Catalyst Pharmaceuticals to Present at Rodman & Renshaws 18th Annual Global Investment Conference GlobeNewswire
Sep-06-16 04:02AM  What Were Looking For From The Catalyst Pharmaceuticals Inc (CPRX) Data at Insider Monkey
Sep-02-16 04:32PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.29%
10:40AM  Catalyst Pharmaceuticals Announces FDA Orphan Drug Designation of Firdapse for the Treatment of Myasthenia Gravis GlobeNewswire
Aug-19-16 07:57AM  These 7 Stocks Under $10 Could Make You a Lot of Money +9.30%
Aug-18-16 08:45AM  Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Up 6.3% +6.57%
Aug-09-16 06:06PM  Catalyst reports 2Q loss
04:35PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:17PM  Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update GlobeNewswire
04:10PM  CATALYST PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which is in second Phase III clinical trials for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as well as is in Phase II/III clinical trial for the treatment of anti-MuSK antibody positive myasthenia gravis. The company also develops CPP-115, a gamma-aminobutyric acid aminotransferase inhibitor that is in Phase Ib clinical trial for the treatment of epilepsy, infantile spams, and Tourette's disorder; and CPP-109 to treat Tourette's disorder. It has a strategic collaboration with BioMarin Pharmaceutical Inc. for the development of Firdapse. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Keeffe Charles BDirectorNov 16Option Exercise0.4750,00023,500513,376Nov 17 05:09 PM
COELHO PHILIP HDirectorNov 09Option Exercise0.4750,00023,500223,287Nov 13 04:22 PM
Tierney David SDirectorNov 09Option Exercise0.4750,00023,500313,401Nov 13 04:20 PM
MCENANY PATRICK JPresident and CEONov 06Option Exercise0.47200,00094,0004,671,026Nov 07 05:13 PM
GRANDE ALICIAChief Financial OfficerNov 06Option Exercise0.47200,00094,000396,346Nov 07 05:12 PM
Miller SteveChief Operating OfficerNov 06Option Exercise0.47200,00094,000657,687Nov 07 05:12 PM
MCENANY PATRICK JPresident and CEOSep 05Buy2.5820,00051,5604,471,026Sep 05 11:00 AM
MCENANY PATRICK JPresident and CEOMay 22Option Exercise1.0431,25032,5004,451,026May 22 02:04 PM
O'Keeffe Charles BDirectorMay 11Option Exercise1.0431,25032,500463,376May 15 04:54 PM